TCGA-97-8552, TCGA-97-8552SENT_1,"SURGICAL PATHOLOGY REPORT","{SURGICAL,PATHOLOGY,REPORT}","{surgical,pathology,report}","{JJ,NN,NN}","{3,3,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_2,"COLLECTION DATE : ? SPECIIVIENS : 1 .","{COLLECTION,DATE,:,?,SPECIIVIENS,:,1,.}","{COLLECTION,DATE,:,?,speciivien,:,1,.}","{NNP,NNP,:,CD,NNS,:,CD,.}","{2,0,0,5,2,0,5,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_3,"BASILAR SEGMENT LEFT LOWER LOBE 2 .","{BASILAR,SEGMENT,LEFT,LOWER,LOBE,2,.}","{BASILAR,SEGMENT,LEFT,LOWER,lobe,2,.}","{NNP,NNP,NNP,NNP,NN,CD,.}","{4,4,4,0,4,5,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_4,"LEVEL 11 LYMPH NODE LEFT 3 .","{LEVEL,11,LYMPH,NODE,LEFT,3,.}","{level,11,LYMPH,NODE,LEFT,3,.}","{NN,CD,NNP,NNP,NNP,CD,.}","{4,4,4,0,4,6,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_5,"LEVEL 5 LYMPH NODE LEFT 4 .","{LEVEL,5,LYMPH,NODE,LEFT,4,.}","{level,5,LYMPH,NODE,LEFT,4,.}","{NN,CD,NNP,NNP,NNP,CD,.}","{4,4,4,0,4,6,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_6,"LEVEL 6 LYMPH NODE LEFT 5 .","{LEVEL,6,LYMPH,NODE,LEFT,5,.}","{level,6,LYMPH,NODE,LEFT,5,.}","{NN,CD,NNP,NNP,NNP,CD,.}","{4,4,4,0,4,6,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_7,"LEVEL 7 LYMPH NODE SEE ADDENDUM","{LEVEL,7,LYMPH,NODE,SEE,ADDENDUM}","{level,7,lymph,node,see,addendum}","{NN,CD,NN,NN,VBP,NN}","{4,4,4,0,4,5}","{}"
TCGA-97-8552, TCGA-97-8552SENT_8,"Reason For Addendum # 1 : Molecular Studies Reason For Addendum # 2 : Molecular Studies Reason For Addendum # 3 : Molecular Studies DIAGNOSIS :","{Reason,For,Addendum,#,1,:,Molecular,Studies,Reason,For,Addendum,#,2,:,Molecular,Studies,Reason,For,Addendum,#,3,:,Molecular,Studies,DIAGNOSIS,:}","{reason,for,Addendum,#,1,:,molecular,study,reason,for,Addendum,#,2,:,molecular,study,reason,for,Addendum,#,3,:,molecular,study,diagnosis,:}","{NN,IN,NNP,#,CD,:,JJ,NNS,NN,IN,NNP,#,CD,:,JJ,NNS,NN,IN,NNP,#,CD,:,JJ,NNS,NNS,:}","{0,0,1,5,1,0,9,9,1,0,9,13,11,0,17,17,1,0,17,21,19,0,24,1,24,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_9,"2 .","{2,.}","{2,.}","{LS,.}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_10,"LYMPH NODE LEFT LEVEL 11 : BIOPSY - ONE BENIGN LYMPH NODE ( 0/1 ) .","{LYMPH,NODE,LEFT,LEVEL,11,:,BIOPSY,-,ONE,BENIGN,LYMPH,NODE,(,0/1,),.}","{lymph,node,LEFT,LEVEL,11,:,biopsy,-,one,benign,lymph,node,(,0/1,),.}","{NN,NN,NNP,NNP,CD,:,NN,:,CD,JJ,NN,NN,CD,CD,NN,.}","{2,0,5,2,5,0,2,0,13,13,13,2,15,16,13,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_11,"3 .","{3,.}","{3,.}","{LS,.}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_12,"LYMPH NODE LEFT LEVEL 5 : BIOPSY - ONE BENIGN LYMPH NODE ( 0/1 ) .","{LYMPH,NODE,LEFT,LEVEL,5,:,BIOPSY,-,ONE,BENIGN,LYMPH,NODE,(,0/1,),.}","{lymph,node,LEFT,LEVEL,5,:,biopsy,-,one,benign,lymph,node,(,0/1,),.}","{NN,NN,NNP,NNP,CD,:,NN,:,CD,JJ,NN,NN,CD,CD,NN,.}","{2,0,5,2,5,0,2,0,13,13,13,2,15,16,13,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_13,"4 .","{4,.}","{4,.}","{LS,.}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_14,"LYMPH NODE LEFT LEVEL 6 : BIOPSY - ONE BENIGN LYMPH NODE ( 0/1 ) .","{LYMPH,NODE,LEFT,LEVEL,6,:,BIOPSY,-,ONE,BENIGN,LYMPH,NODE,(,0/1,),.}","{lymph,node,LEFT,LEVEL,6,:,biopsy,-,one,benign,lymph,node,(,0/1,),.}","{NN,NN,NNP,NNP,CD,:,NN,:,CD,JJ,NN,NN,CD,CD,NN,.}","{2,0,5,2,5,0,2,0,13,13,13,2,15,16,13,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_15,"5 .","{5,.}","{5,.}","{CD,.}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_16,"LYMPH NODE LEVEL 7 : BIOPSY - ONE BENIGN LYMPH NODE ( 0/1 ) .","{LYMPH,NODE,LEVEL,7,:,BIOPSY,-,ONE,BENIGN,LYMPH,NODE,(,0/1,),.}","{lymph,node,level,7,:,biopsy,-,one,benign,lymph,node,(,0/1,),.}","{NN,NN,NN,CD,:,NN,:,CD,JJ,NN,NN,CD,CD,NN,.}","{2,0,2,4,0,2,0,12,12,12,2,14,15,12,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_17,"Specimens : 1 : BASILAR SEGMENT LEFT LOWER LOBE 2 : LEVEL 11 LYMPH NODE LEFT 3 : LEVEL 5 LYMPH NODE LEFT 4 : LEVEL 6 LYMPH NODE LEFT","{Specimens,:,1,:,BASILAR,SEGMENT,LEFT,LOWER,LOBE,2,:,LEVEL,11,LYMPH,NODE,LEFT,3,:,LEVEL,5,LYMPH,NODE,LEFT,4,:,LEVEL,6,LYMPH,NODE,LEFT}","{specimen,:,1,:,BASILAR,SEGMENT,LEFT,LOWER,lobe,2,:,level,11,LYMPH,NODE,LEFT,3,:,level,5,LYMPH,NODE,LEFT,4,:,level,6,LYMPH,NODE,LEFT}","{NNS,:,CD,:,NNP,NNP,NNP,NNP,NN,CD,:,NN,CD,NNP,NNP,NNP,CD,:,NN,CD,NNP,NNP,NNP,CD,:,NN,CD,NNP,NNP,NNP}","{0,0,1,0,8,8,8,3,8,9,0,15,15,15,8,15,17,0,23,23,23,8,23,25,0,31,31,31,8,31}","{}"
TCGA-97-8552, TCGA-97-8552SENT_18,"5 : LEVEL 7 LYMPH NODE","{5,:,LEVEL,7,LYMPH,NODE}","{5,:,level,7,lymph,node}","{CD,:,NN,CD,NN,NN}","{0,0,6,6,6,1}","{}"
TCGA-97-8552, TCGA-97-8552SENT_19,"LUNG : Resection SPECIMEN Specimen : Lobe ( s ) of lung ( specify ) left lower lobe Procedure : Segmentectomy Specimen Laterality : Left Tumor Site : Lower lobe Tumor Focality : Unifocal TUMOR Histologic Type : Adenocarcinoma mixed subtype Histologic Grade : G1 : Well differentiated EXTENT Tumor Size : Greatest dimension ( cm ) 1.5 cm Visceral Pleura Invasion : Not identified MARGINS Bronchial Margin Bronchial Margin Involvement by Invasive Carcinoma : Uninvolved by invasive carcinoma Vascular Margin : Uninvolved by invasive carcinoma ACCESSORY FINDINGS Lymph-Vascular Invasion : Not identified STAGE ( pTNM ) Primary Tumor ( pT ) : pT1a : Tumor 2 cm or less in greatest dimension surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus ( i.e. not in the main bronchus ) ; or Superficial spreading tumor of any size with its invasive component limited to the bronchial wall which may extend proximally to the main bronchus Regional Lymph Nodes ( pN ) pNo : No regional lymph node metastasis Number Examined 4 Number Involved o Distant Metastases ( pM ) : Not applicable","{LUNG,:,Resection,SPECIMEN,Specimen,:,Lobe,(,s,),of,lung,(,specify,),left,lower,lobe,Procedure,:,Segmentectomy,Specimen,Laterality,:,Left,Tumor,Site,:,Lower,lobe,Tumor,Focality,:,Unifocal,TUMOR,Histologic,Type,:,Adenocarcinoma,mixed,subtype,Histologic,Grade,:,G1,:,Well,differentiated,EXTENT,Tumor,Size,:,Greatest,dimension,(,cm,),1.5,cm,Visceral,Pleura,Invasion,:,Not,identified,MARGINS,Bronchial,Margin,Bronchial,Margin,Involvement,by,Invasive,Carcinoma,:,Uninvolved,by,invasive,carcinoma,Vascular,Margin,:,Uninvolved,by,invasive,carcinoma,ACCESSORY,FINDINGS,Lymph-Vascular,Invasion,:,Not,identified,STAGE,(,pTNM,),Primary,Tumor,(,pT,),:,pT1a,:,Tumor,2,cm,or,less,in,greatest,dimension,surrounded,by,lung,or,visceral,pleura,without,bronchoscopic,evidence,of,invasion,more,proximal,than,the,lobar,bronchus,(,i.e.,not,in,the,main,bronchus,),;,or,Superficial,spreading,tumor,of,any,size,with,its,invasive,component,limited,to,the,bronchial,wall,which,may,extend,proximally,to,the,main,bronchus,Regional,Lymph,Nodes,(,pN,),pNo,:,No,regional,lymph,node,metastasis,Number,Examined,4,Number,Involved,o,Distant,Metastases,(,pM,),:,Not,applicable}","{lung,:,Resection,SPECIMEN,Specimen,:,lobe,(,s,),of,lung,(,specify,),leave,lower,lobe,Procedure,:,Segmentectomy,Specimen,Laterality,:,leave,tumor,site,:,lower,lobe,tumor,focality,:,unifocal,tumor,histologic,type,:,adenocarcinoma,mixed,subtype,histologic,Grade,:,g1,:,well,differentiate,EXTENT,tumor,size,:,greatest,dimension,(,cm,),1.5,cm,visceral,Pleura,Invasion,:,not,identify,margin,bronchial,margin,bronchial,margin,involvement,by,Invasive,Carcinoma,:,uninvolved,by,invasive,carcinoma,vascular,margin,:,uninvolve,by,invasive,carcinoma,accessory,finding,lymph-vascular,Invasion,:,not,identify,stage,(,ptnm,),primary,tumor,(,pt,),:,pt1a,:,tumor,2,cm,or,less,in,greatest,dimension,surround,by,lung,or,visceral,pleuron,without,bronchoscopic,evidence,of,invasion,more,proximal,than,the,lobar,bronchus,(,i.e.,not,in,the,main,bronchus,),;,or,superficial,spreading,tumor,of,any,size,with,its,invasive,component,limit,to,the,bronchial,wall,which,may,extend,proximally,to,the,main,bronchus,Regional,Lymph,Nodes,(,pn,),pno,:,no,regional,lymph,node,metastasis,number,examine,4,Number,involve,o,distant,metastase,(,pm,),:,not,applicable}","{NN,:,NNP,NNP,NNP,:,NN,CD,NNS,CD,IN,NN,NN,VB,CD,VBD,JJR,NN,NNP,:,NNP,NNP,NNP,:,VBN,NN,NN,:,JJR,NN,NN,NN,:,JJ,NN,JJ,NN,:,NN,JJ,NN,JJ,NNP,:,NN,:,UH,VBN,NNP,NN,NN,:,JJS,NN,CD,NN,NN,CD,NN,JJ,NNP,NNP,:,RB,VBN,NNS,JJ,NN,JJ,NN,NN,IN,NNP,NNP,:,JJ,IN,JJ,NN,JJ,NN,:,VBN,IN,JJ,NN,NN,NNS,JJ,NNP,:,RB,VBN,NN,CD,NN,CD,JJ,NN,CD,NN,CD,:,NN,:,NN,CD,NN,CC,JJR,IN,JJS,NN,VBN,IN,NN,CC,JJ,NN,IN,JJ,NN,IN,NN,RBR,JJ,IN,DT,JJ,NN,CD,FW,RB,IN,DT,JJ,NN,NN,:,CC,JJ,NN,NN,IN,DT,NN,IN,PRP$,JJ,NN,VBN,TO,DT,JJ,NN,WDT,MD,VB,RB,TO,DT,JJ,NNS,NNP,NNP,NNP,CD,NN,CD,NN,:,DT,JJ,NN,NN,NN,NN,VBN,CD,NNP,VBN,NN,JJ,NNS,VBP,NN,CD,:,RB,JJ}","{195,0,195,195,195,0,195,195,195,195,195,195,195,195,195,195,195,195,195,0,195,195,195,0,195,195,195,0,195,195,195,195,0,195,195,195,195,0,195,195,195,195,195,0,195,0,195,195,195,195,195,0,195,195,195,195,195,195,195,195,195,195,0,195,195,195,195,195,195,195,195,195,195,195,0,195,195,195,195,195,195,0,195,195,195,195,195,195,195,195,0,195,195,195,195,195,195,195,195,195,195,195,0,195,0,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,0,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,0,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,195,0,195,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_20,"Pathologist","{Pathologist}","{pathologist}","{NN}","{0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_21,"CLINICAL HISTORY AND PRE ? OPERATIVE DIAGNOSIS : - neVer ? smoker with a 1.5 cm LLL nodule .","{CLINICAL,HISTORY,AND,PRE,?,OPERATIVE,DIAGNOSIS,:,-,neVer,?,smoker,with,a,1.5,cm,LLL,nodule,.}","{clinical,history,and,pre,?,OPERATIVE,DIAGNOSIS,:,-,never,?,smoker,with,a,1.5,cm,lll,nodule,.}","{JJ,NN,CC,NN,CD,NNP,NNP,:,:,NN,CD,NN,IN,DT,CD,NN,NN,NN,.}","{2,0,0,7,7,7,2,0,0,12,12,2,0,18,18,18,18,12,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_22,"MACROSCOPIC DESCRIPTION : The specimen is received in saline in five parts each labeled with the patient ? s name .","{MACROSCOPIC,DESCRIPTION,:,The,specimen,is,received,in,saline,in,five,parts,each,labeled,with,the,patient,?,s,name,.}","{macroscopic,description,:,the,specimen,be,receive,in,saline,in,five,part,each,label,with,the,patient,?,s,name,.}","{JJ,NN,:,DT,NN,VBZ,VBN,IN,NN,IN,CD,NNS,DT,VBN,IN,DT,NN,CD,NNS,NN,.}","{2,0,0,5,7,7,2,0,7,0,13,7,7,15,0,19,16,21,19,21,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_23,"1 .","{1,.}","{1,.}","{LS,.}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_24,"Part one is labeled ? basilar segment left lower lobe stitch marks tumor ? .","{Part,one,is,labeled,?,basilar,segment,left,lower,lobe,stitch,marks,tumor,?,.}","{Part,one,be,label,?,basilar,segment,leave,lower,lobe,stitch,mark,tumor,?,.}","{NNP,CD,VBZ,VBN,RB,JJ,NN,VBD,JJR,NN,VBP,NNS,NN,NN,.}","{4,1,4,0,6,7,8,4,10,8,4,12,15,4,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_25,"It consists of a segmentectomy specimen of the lung measuring 15 X 10 X 4 cm .","{It,consists,of,a,segmentectomy,specimen,of,the,lung,measuring,15,X,10,X,4,cm,.}","{it,consist,of,a,segmentectomy,specimen,of,the,lung,measure,15,x,10,x,4,cm,.}","{PRP,VBZ,IN,DT,NN,NN,IN,DT,NN,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,6,6,2,0,9,6,9,12,10,14,10,16,14,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_26,"The staple line measures 8 cm in length which is shaved and the parenchyma around is inked black .","{The,staple,line,measures,8,cm,in,length,which,is,shaved,and,the,parenchyma,around,is,inked,black,.}","{the,staple,line,measure,8,cm,in,length,which,be,shave,and,the,parenchyma,around,be,ink,black,.}","{DT,JJ,NN,NNS,CD,NN,IN,NN,WDT,VBZ,VBN,CC,DT,NN,IN,VBZ,VBN,JJ,.}","{4,4,4,17,6,4,0,4,11,11,8,0,14,11,14,17,0,17,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_27,"The specimen is received precut and the precut area is marked with a stitch which reveals a gray ? pink slightly finn nodule measuring 1.5 X 1.2 cm .","{The,specimen,is,received,precut,and,the,precut,area,is,marked,with,a,stitch,which,reveals,a,gray,?,pink,slightly,finn,nodule,measuring,1.5,X,1.2,cm,.}","{the,specimen,be,receive,precut,and,the,precut,area,be,mark,with,a,stitch,which,reveal,a,gray,?,pink,slightly,finn,nodule,measure,1.5,x,1.2,cm,.}","{DT,NN,VBZ,VBN,JJ,CC,DT,JJ,NN,VBZ,VBN,IN,DT,NN,WDT,VBZ,DT,JJ,NN,NN,RB,JJ,NN,VBG,CD,NN,CD,NN,.}","{2,4,4,11,4,0,9,9,5,11,0,0,14,11,16,14,20,20,20,16,24,23,21,20,28,28,28,11,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_28,"The nodule is located subpleural and 3 cm from the hilum .","{The,nodule,is,located,subpleural,and,3,cm,from,the,hilum,.}","{the,nodule,be,located,subpleural,and,3,cm,from,the,hilum,.}","{DT,NN,VBZ,JJ,JJ,CC,CD,NN,IN,DT,NN,.}","{2,5,5,5,0,0,8,5,0,11,8,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_29,"The pleura is gray ? pink glistening and lightly mottled with fine black streaks .","{The,pleura,is,gray,?,pink,glistening,and,lightly,mottled,with,fine,black,streaks,.}","{the,pleuron,be,gray,?,pink,glisten,and,lightly,mottle,with,fine,black,streak,.}","{DT,NN,VBZ,JJ,NN,NN,VBG,CC,RB,VBN,IN,JJ,JJ,NNS,.}","{2,6,6,6,6,0,6,0,8,8,0,15,15,11,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_30,"The remainder of the parenchyma is pink ? red blotchy and crepitant .","{The,remainder,of,the,parenchyma,is,pink,?,red,blotchy,and,crepitant,.}","{the,remainder,of,the,parenchyma,be,pink,?,red,blotchy,and,crepitant,.}","{DT,NN,IN,DT,NN,VBZ,JJ,NN,NN,JJ,CC,JJ,.}","{2,9,0,5,2,9,9,9,0,9,0,9,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_31,"Representative sections are submitted .","{Representative,sections,are,submitted,.}","{Representative,section,be,submit,.}","{NNP,NNS,VBP,VBN,.}","{2,4,4,0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_32,"2 .","{2,.}","{2,.}","{LS,.}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_33,"Part two is labeled ? level ll lymph node left ? .","{Part,two,is,labeled,?,level,ll,lymph,node,left,?,.}","{Part,two,be,label,?,level,ll,lymph,node,leave,?,.}","{NNP,CD,VBZ,VBN,JJ,NN,NN,NN,NN,VBD,CD,.}","{4,1,4,0,7,7,4,9,10,7,10,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_34,"It consists of one anthracotic lymph node measuring 0.8 X 0.6 X 0.3 cm .","{It,consists,of,one,anthracotic,lymph,node,measuring,0.8,X,0.6,X,0.3,cm,.}","{it,consist,of,one,anthracotic,lymph,node,measure,0.8,x,0.6,x,0.3,cm,.}","{PRP,VBZ,IN,CD,JJ,NN,NN,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,7,7,7,2,7,10,8,12,8,14,12,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_35,"Entire lymph node is submitted in one cassette .","{Entire,lymph,node,is,submitted,in,one,cassette,.}","{entire,lymph,node,be,submit,in,one,cassette,.}","{JJ,NN,NN,VBZ,VBN,IN,CD,NN,.}","{3,3,5,5,0,0,8,5,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_36,"3 .","{3,.}","{3,.}","{LS,.}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_37,"Part three is labeled ? level 5 lymph node left ? .","{Part,three,is,labeled,?,level,5,lymph,node,left,?,.}","{Part,three,be,label,?,level,5,lymph,node,leave,?,.}","{NNP,CD,VBZ,VBN,JJ,NN,CD,NN,NN,VBD,CD,.}","{4,1,4,0,9,9,9,9,10,4,10,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_38,"It consists of one anthracotic lymph node measuring 1 X 0.8 X 0.5 cm .","{It,consists,of,one,anthracotic,lymph,node,measuring,1,X,0.8,X,0.5,cm,.}","{it,consist,of,one,anthracotic,lymph,node,measure,1,x,0.8,x,0.5,cm,.}","{PRP,VBZ,IN,CD,JJ,NN,NN,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,7,7,7,8,2,10,14,12,10,14,8,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_39,"Entire lymph node is submitted in one cassette .","{Entire,lymph,node,is,submitted,in,one,cassette,.}","{entire,lymph,node,be,submit,in,one,cassette,.}","{JJ,NN,NN,VBZ,VBN,IN,CD,NN,.}","{3,3,5,5,0,0,8,5,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_40,"4 .","{4,.}","{4,.}","{LS,.}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_41,"Part four is labeled ? level 6 lymph node left ? .","{Part,four,is,labeled,?,level,6,lymph,node,left,?,.}","{Part,four,be,label,?,level,6,lymph,node,leave,?,.}","{NNP,CD,VBZ,VBN,JJ,NN,CD,NN,NN,VBD,CD,.}","{4,1,4,0,9,9,9,9,10,4,10,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_42,"It consists of one lymph node measuring 0.6 X 0.5 X 0.3 cm .","{It,consists,of,one,lymph,node,measuring,0.6,X,0.5,X,0.3,cm,.}","{it,consist,of,one,lymph,node,measure,0.6,x,0.5,x,0.3,cm,.}","{PRP,VBZ,IN,CD,NN,NN,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,6,6,2,6,9,7,11,9,13,7,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_43,"Entire lymph node is submitted in one cassette .","{Entire,lymph,node,is,submitted,in,one,cassette,.}","{entire,lymph,node,be,submit,in,one,cassette,.}","{JJ,NN,NN,VBZ,VBN,IN,CD,NN,.}","{3,3,5,5,0,0,8,5,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_44,"5 .","{5,.}","{5,.}","{CD,.}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_45,"Part five is labeled ? level 7 lymph node ? .","{Part,five,is,labeled,?,level,7,lymph,node,?,.}","{Part,five,be,label,?,level,7,lymph,node,?,.}","{NNP,CD,VBZ,VBN,JJ,NN,CD,NN,NN,NN,.}","{4,1,4,0,10,10,10,10,10,4,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_46,"It consists of one anthracotic lymph node measuring 0.3 X 0.3 X 0.2 cm .","{It,consists,of,one,anthracotic,lymph,node,measuring,0.3,X,0.3,X,0.2,cm,.}","{it,consist,of,one,anthracotic,lymph,node,measure,0.3,x,0.3,x,0.2,cm,.}","{PRP,VBZ,IN,CD,JJ,NN,NN,VBG,CD,NN,CD,NN,CD,NN,.}","{2,0,0,7,7,7,2,7,10,8,12,8,14,12,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_47,"Entire lymph node is submitted in one cassette .","{Entire,lymph,node,is,submitted,in,one,cassette,.}","{entire,lymph,node,be,submit,in,one,cassette,.}","{JJ,NN,NN,VBZ,VBN,IN,CD,NN,.}","{3,3,5,5,0,0,8,5,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_48,"SUMMARY OF SECTIONS : lA ? lC nodule from the stitch area lD staple line margin lE bronchial resection margin shaved lF random section of the lung parenchyma 2A in toto 3A in toto 4A in toto 5A in toto","{SUMMARY,OF,SECTIONS,:,lA,?,lC,nodule,from,the,stitch,area,lD,staple,line,margin,lE,bronchial,resection,margin,shaved,lF,random,section,of,the,lung,parenchyma,2A,in,toto,3A,in,toto,4A,in,toto,5A,in,toto}","{summary,of,section,:,la,?,lc,nodule,from,the,stitch,area,ld,staple,line,margin,le,bronchial,resection,margin,shave,lf,random,section,of,the,lung,parenchyma,2a,in,toto,3a,in,toto,4a,in,toto,5a,in,toto}","{NN,IN,NNS,:,NN,CD,NN,NN,IN,DT,NN,NN,NN,NN,NN,NN,NN,JJ,NN,NN,VBD,NN,JJ,NN,IN,DT,NN,NN,NN,IN,NN,NN,IN,NN,NN,IN,NN,NN,IN,NN}","{22,0,1,0,8,8,8,1,0,20,20,20,20,20,20,20,20,20,20,8,0,25,25,22,0,30,30,30,25,0,33,22,0,36,33,0,39,22,0,39}","{}"
TCGA-97-8552, TCGA-97-8552SENT_49,"SPECIAL PROCEDURES :","{SPECIAL,PROCEDURES,:}","{special,procedure,:}","{JJ,NNS,:}","{2,0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_50,"Final Dia nosis erfonned by","{Final,Dia,nosis,erfonned,by}","{final,dium,nosis,erfonn,by}","{JJ,NN,NN,VBN,IN}","{3,3,4,0,4}","{}"
TCGA-97-8552, TCGA-97-8552SENT_51,"ADDENDUM # 1 FOR MOLECULAR TESTS : KRAS EGFR and ALK FISH were sent .","{ADDENDUM,#,1,FOR,MOLECULAR,TESTS,:,KRAS,EGFR,and,ALK,FISH,were,sent,.}","{ADDENDUM,#,1,for,molecular,test,:,kra,egfr,and,ALK,fish,be,send,.}","{NNP,#,CD,IN,NN,NNS,:,NNS,NN,CC,NNP,NN,VBD,VBN,.}","{0,3,1,0,6,1,0,15,15,0,13,8,15,1,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_52,"( -2 for .","{(,-2,for,.}","{(,-2,for,.}","{NN,CD,IN,.}","{0,1,1,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_53,"The test is to be ierformed on tissue from caseaccession number were retrieved from archives .","{The,test,is,to,be,ierformed,on,tissue,from,caseaccession,number,were,retrieved,from,archives,.}","{the,test,be,to,be,ierform,on,tissue,from,caseaccession,number,be,retrieve,from,archive,.}","{DT,NN,VBZ,TO,VB,VBN,IN,NN,IN,NN,NN,VBD,VBN,IN,NNS,.}","{2,3,0,6,6,3,0,6,0,11,6,13,11,0,13,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_54,"The pathologist whose signature appears below reviewed the original pathology report examined candidate H&E slides and selected block lA appropriate to the specifications of the ordered molecular analysis .","{The,pathologist,whose,signature,appears,below,reviewed,the,original,pathology,report,examined,candidate,H&E,slides,and,selected,block,lA,appropriate,to,the,specifications,of,the,ordered,molecular,analysis,.}","{the,pathologist,whose,signature,appear,below,review,the,original,pathology,report,examine,candidate,h&e,slide,and,select,block,la,appropriate,to,the,specification,of,the,order,molecular,analysis,.}","{DT,NN,WP$,NN,VBZ,IN,VBN,DT,JJ,NN,NN,VBN,NN,NN,NNS,CC,VBN,NN,NN,JJ,TO,DT,NNS,IN,DT,VBN,JJ,NN,.}","{2,0,4,5,2,5,2,11,11,11,7,2,16,16,13,0,7,21,22,19,0,25,22,0,30,30,30,25,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_55,"Xl H&E and X9 unstained slides were prepared and forwarded to ?","{Xl,H&E,and,X9,unstained,slides,were,prepared,and,forwarded,to,?}","{xl,h&e,and,x9,unstained,slide,be,prepare,and,forward,to,?}","{NN,NN,CC,NN,JJ,NNS,VBD,VBN,CC,VBN,TO,VB}","{2,8,0,6,6,2,8,0,0,8,12,8}","{}"
TCGA-97-8552, TCGA-97-8552SENT_56,"where the subject molecular test will be performed .","{where,the,subject,molecular,test,will,be,performed,.}","{where,the,subject,molecular,test,will,be,perform,.}","{WRB,DT,JJ,JJ,NN,MD,VB,VBN,.}","{8,5,5,5,8,8,8,0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_57,"An addendum report will be issued when the results of this molecular test are available .","{An,addendum,report,will,be,issued,when,the,results,of,this,molecular,test,are,available,.}","{a,addendum,report,will,be,issue,when,the,result,of,this,molecular,test,be,available,.}","{DT,NN,NN,MD,VB,VBN,WRB,DT,NNS,IN,DT,JJ,NN,VBP,JJ,.}","{3,3,6,6,6,0,15,9,15,0,13,13,9,15,6,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_58,"Addendum # 1 erformed by ADDENDUM # 2 :","{Addendum,#,1,erformed,by,ADDENDUM,#,2,:}","{Addendum,#,1,erform,by,ADDENDUM,#,2,:}","{NNP,#,CD,VBN,IN,NNP,#,CD,:}","{0,3,1,1,0,4,8,6,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_59,"MOLECULAR ONCOLOGY","{MOLECULAR,ONCOLOGY}","{molecular,oncology}","{JJ,NN}","{2,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_60,"KRAS MUTATION ANALYSIS RESULTS : Wild ? type gene","{KRAS,MUTATION,ANALYSIS,RESULTS,:,Wild,?,type,gene}","{KRAS,MUTATION,ANALYSIS,result,:,Wild,?,type,gene}","{NNP,NNP,NNP,NNS,:,NNP,CD,NN,NN}","{4,4,4,0,0,4,9,9,6}","{}"
TCGA-97-8552, TCGA-97-8552SENT_61,"INTERPRETATION : No mutations were identified at codons 12 and 13 of the KRAS gene .","{INTERPRETATION,:,No,mutations,were,identified,at,codons,12,and,13,of,the,KRAS,gene,.}","{interpretation,:,no,mutation,be,identify,at,codon,12,and,13,of,the,KRAS,gene,.}","{NN,:,DT,NNS,VBD,VBN,IN,NNS,CD,CC,CD,IN,DT,NNP,NN,.}","{0,0,4,6,6,1,0,6,8,0,6,0,15,15,8,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_62,"COMMENT : Mutations in the KRAS gene are reported to be associated with poor prognosis and resistance to targeted tyrosine kinase inhibitor therapies in patients with non ? small ? cell lung cancer ( NSCLC ) .","{COMMENT,:,Mutations,in,the,KRAS,gene,are,reported,to,be,associated,with,poor,prognosis,and,resistance,to,targeted,tyrosine,kinase,inhibitor,therapies,in,patients,with,non,?,small,?,cell,lung,cancer,(,NSCLC,),.}","{COMMENT,:,mutation,in,the,KRAS,gene,be,report,to,be,associate,with,poor,prognosis,and,resistance,to,target,tyrosine,kinase,inhibitor,therapy,in,patient,with,non,?,small,?,cell,lung,cancer,(,nsclc,),.}","{NNP,:,NNS,IN,DT,NNP,NN,VBP,VBN,TO,VB,VBN,IN,JJ,NN,CC,NN,TO,VBN,NN,NN,NN,NNS,IN,NNS,IN,JJ,JJ,JJ,NN,NN,NN,NN,CD,NN,NN,.}","{0,0,9,0,7,7,3,9,1,12,12,9,0,15,12,0,15,0,37,24,24,24,20,0,24,0,36,36,36,36,36,36,36,36,26,12,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_63,"KRAS mutations occur in 15-30 % of NSCLC patients and are strongly associated with adenocarcinoma and smoking history .","{KRAS,mutations,occur,in,15-30,%,of,NSCLC,patients,and,are,strongly,associated,with,adenocarcinoma,and,smoking,history,.}","{KRAS,mutation,occur,in,15-30,%,of,nsclc,patient,and,be,strongly,associate,with,adenocarcinoma,and,smoking,history,.}","{NNP,NNS,VBP,IN,CD,NN,IN,NN,NNS,CC,VBP,RB,VBN,IN,NN,CC,NN,NN,.}","{2,3,0,0,6,3,0,9,6,0,13,13,3,0,18,0,15,13,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_64,"This assay analyzes codons l2 and 13 in exon 2 of the KRAS gene ; based on the current literature approximately 98 % of mutations are expected to occur in these codons .","{This,assay,analyzes,codons,l2,and,13,in,exon,2,of,the,KRAS,gene,;,based,on,the,current,literature,approximately,98,%,of,mutations,are,expected,to,occur,in,these,codons,.}","{this,assay,analyze,codon,l2,and,13,in,exon,2,of,the,KRAS,gene,;,base,on,the,current,literature,approximately,98,%,of,mutation,be,expect,to,occur,in,these,codon,.}","{DT,NN,VBZ,NNS,NN,CC,CD,IN,NN,CD,IN,DT,NNP,NN,:,VBN,IN,DT,JJ,NN,RB,CD,NN,IN,NNS,VBP,VBN,TO,VB,IN,DT,NNS,.}","{2,3,0,5,3,0,5,0,3,9,0,14,14,9,0,0,28,20,20,28,23,24,28,0,24,28,3,30,28,0,33,30,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_65,"The analytical sensitivity of the assay is approximately 10 % ; thus mutations present in a low percentage of cells may not be detected .","{The,analytical,sensitivity,of,the,assay,is,approximately,10,%,;,thus,mutations,present,in,a,low,percentage,of,cells,may,not,be,detected,.}","{the,analytical,sensitivity,of,the,assay,be,approximately,10,%,;,thus,mutation,present,in,a,low,percentage,of,cell,may,not,be,detect,.}","{DT,JJ,NN,IN,DT,NN,VBZ,RB,CD,NN,:,RB,NNS,JJ,IN,DT,JJ,NN,IN,NNS,MD,RB,VB,VBN,.}","{3,3,10,0,6,3,10,9,10,0,0,24,24,13,0,18,18,14,0,18,24,24,24,10,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_66,"This test is validated for use in identifying KRAS codon 12 and codon 13 mutations in fresh frozen or fonnalin ? fixed paraffin embedded tissue .","{This,test,is,validated,for,use,in,identifying,KRAS,codon,12,and,codon,13,mutations,in,fresh,frozen,or,fonnalin,?,fixed,paraffin,embedded,tissue,.}","{this,test,be,validate,for,use,in,identify,KRAS,codon,12,and,codon,13,mutation,in,fresh,frozen,or,fonnalin,?,fix,paraffin,embedded,tissue,.}","{DT,NN,VBZ,VBN,IN,NN,IN,VBG,NNP,NN,CD,CC,NN,CD,NNS,IN,JJ,JJ,CC,NN,NN,VBN,NN,JJ,NN,.}","{2,4,4,0,0,4,0,4,10,15,10,0,10,15,8,0,19,15,0,23,15,15,27,27,24,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_67,"In particular the test performance has been established in samples of colorectal cancer and non ? small cell lung carcinoma which harbor these mutations although several other tissues are also known to harbor KRAS mutations ( e. g. tumors of pancreas bile duct ovary appendix etc. ) .","{In,particular,the,test,performance,has,been,established,in,samples,of,colorectal,cancer,and,non,?,small,cell,lung,carcinoma,which,harbor,these,mutations,although,several,other,tissues,are,also,known,to,harbor,KRAS,mutations,(,e.,g.,tumors,of,pancreas,bile,duct,ovary,appendix,etc.,),.}","{in,particular,the,test,performance,have,be,establish,in,sample,of,colorectal,cancer,and,non,?,small,cell,lung,carcinoma,which,harbor,these,mutation,although,several,other,tissue,be,also,know,to,harbor,KRAS,mutation,(,e.,g.,tumor,of,pancreas,bile,duct,ovary,appendix,etc.,),.}","{IN,JJ,DT,NN,NN,VBZ,VBN,VBN,IN,NNS,IN,JJ,NN,CC,JJ,JJ,JJ,NN,NN,NN,WDT,VBP,DT,NNS,IN,JJ,JJ,NNS,VBP,RB,VBN,TO,VB,NNP,NNS,CD,NN,NN,NNS,IN,NN,NN,NN,NN,NN,FW,FW,.}","{0,8,5,5,8,8,8,0,0,8,0,13,10,0,20,20,20,20,20,10,22,20,24,22,32,29,29,32,32,32,8,34,32,36,40,40,40,40,34,0,40,45,42,42,42,52,42,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_68,"Analysis of EGFR mutation or gene amplification status may provide additional infonnation regarding this patient 's probability of response to targeted tyrosine kinase inhibitor therapies if clinically indicated .","{Analysis,of,EGFR,mutation,or,gene,amplification,status,may,provide,additional,infonnation,regarding,this,patient,'s,probability,of,response,to,targeted,tyrosine,kinase,inhibitor,therapies,if,clinically,indicated,.}","{analysis,of,egfr,mutation,or,gene,amplification,status,may,provide,additional,infonnation,regard,this,patient,'s,probability,of,response,to,target,tyrosine,kinase,inhibitor,therapy,if,clinically,indicate,.}","{NN,IN,NN,NN,CC,NN,NN,NN,MD,VB,JJ,NN,VBG,DT,NN,POS,NN,IN,NN,TO,VBN,NN,NN,NN,NNS,IN,RB,VBN,.}","{10,0,4,1,0,8,8,4,10,0,12,10,0,15,17,0,12,0,17,0,10,25,25,25,21,29,29,21,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_69,"See references .","{See,references,.}","{see,reference,.}","{VB,NNS,.}","{0,1,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_70,"METHOD/LIMITATIONS : Tissue sections are reviewed by a pathologist and relevant tumor is selected for analysis .","{METHOD/LIMITATIONS,:,Tissue,sections,are,reviewed,by,a,pathologist,and,relevant,tumor,is,selected,for,analysis,.}","{METHOD/LIMITATIONS,:,tissue,section,be,review,by,a,pathologist,and,relevant,tumor,be,select,for,analysis,.}","{NNP,:,NN,NNS,VBP,VBN,IN,DT,NN,CC,JJ,NN,VBZ,VBN,IN,NN,.}","{0,0,4,6,6,1,0,9,6,0,12,14,14,6,0,14,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_71,"DNA is isolated from the sample quantified and amplified by polymerase chain reaction ( PCR ) using primers to exon 2 of the KRAS gene .","{DNA,is,isolated,from,the,sample,quantified,and,amplified,by,polymerase,chain,reaction,(,PCR,),using,primers,to,exon,2,of,the,KRAS,gene,.}","{dna,be,isolate,from,the,sample,quantify,and,amplify,by,polymerase,chain,reaction,(,pcr,),use,primer,to,exon,2,of,the,KRAS,gene,.}","{NN,VBZ,VBN,IN,DT,NN,VBN,CC,VBN,IN,NN,NN,NN,CD,NN,NN,VBG,NNS,TO,NN,CD,IN,DT,NNP,NN,.}","{10,3,0,0,6,3,3,0,3,0,17,17,17,17,17,10,17,18,0,18,21,0,26,26,21,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_72,"PCR products are subjected to single nucleotide primer extension to detect mutations at codons l2 and 13 ; primer extension products are analyzed using capillary gel electrophoresis and ?uorescence detection .","{PCR,products,are,subjected,to,single,nucleotide,primer,extension,to,detect,mutations,at,codons,l2,and,13,;,primer,extension,products,are,analyzed,using,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{pcr,product,be,subject,to,single,nucleotide,primer,extension,to,detect,mutation,at,codon,l2,and,13,;,primer,extension,product,be,analyze,use,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{NN,NNS,VBP,VBN,TO,JJ,NN,NN,NN,TO,VB,NNS,IN,NNS,NN,CC,CD,:,NN,NN,NNS,VBP,VBN,VBG,JJ,NN,NN,CC,NN,NN,.}","{2,4,4,0,0,9,9,9,4,11,4,11,0,15,11,0,11,0,21,21,23,23,4,23,27,27,24,0,30,27,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_73,"False positive or negative results may occur for reasons that include genetic variants or somatic heterogeneity of the tissue sample .","{False,positive,or,negative,results,may,occur,for,reasons,that,include,genetic,variants,or,somatic,heterogeneity,of,the,tissue,sample,.}","{false,positive,or,negative,result,may,occur,for,reason,that,include,genetic,variant,or,somatic,heterogeneity,of,the,tissue,sample,.}","{JJ,JJ,CC,JJ,NNS,MD,VB,IN,NNS,WDT,VBP,JJ,NNS,CC,JJ,NN,IN,DT,NN,NN,.}","{5,5,0,2,7,7,0,0,7,11,9,13,11,0,16,13,0,20,20,16,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_74,"REFERENCES :","{REFERENCES,:}","{reference,:}","{NNS,:}","{0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_75,"Addendum # 2 erformed by f ADDENDUM # 3 : INTEGRATED ONCOLOGY EGFR Mutation Analysis","{Addendum,#,2,erformed,by,f,ADDENDUM,#,3,:,INTEGRATED,ONCOLOGY,EGFR,Mutation,Analysis}","{Addendum,#,2,erform,by,f,addendum,#,3,:,INTEGRATED,ONCOLOGY,egfr,mutation,analysis}","{NNP,#,CD,VBN,IN,FW,FW,#,CD,:,NNP,NNP,NN,NN,NN}","{0,3,1,1,0,7,4,9,7,0,12,7,15,15,12}","{}"
TCGA-97-8552, TCGA-97-8552SENT_76,"Body Site : Left lower lobe of lung","{Body,Site,:,Left,lower,lobe,of,lung}","{body,site,:,leave,lower,lobe,of,lung}","{NN,NN,:,VBN,JJR,NN,IN,NN}","{2,0,0,2,6,4,0,6}","{}"
TCGA-97-8552, TCGA-97-8552SENT_77,"Clinical Data : Adenocarcinoma","{Clinical,Data,:,Adenocarcinoma}","{clinical,datum,:,adenocarcinoma}","{JJ,NNS,:,NN}","{2,0,0,2}","{}"
TCGA-97-8552, TCGA-97-8552SENT_78,"RESULTS : Positive for the E746_A750del5 mutation in Exon 19 .","{RESULTS,:,Positive,for,the,E746_A750del5,mutation,in,Exon,19,.}","{result,:,positive,for,the,e746_a750del5,mutation,in,Exon,19,.}","{NNS,:,JJ,IN,DT,NN,NN,IN,NNP,CD,.}","{0,0,1,0,7,7,3,0,7,9,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_79,"INTERPRETATION : Deletion mutations in eXon 19 mostly involving the LREA motif are reported to correlate with responsiveness to EGFR tyrosine kinase inhibitor in patients with non ? small ? cell lung carcinoma .","{INTERPRETATION,:,Deletion,mutations,in,eXon,19,mostly,involving,the,LREA,motif,are,reported,to,correlate,with,responsiveness,to,EGFR,tyrosine,kinase,inhibitor,in,patients,with,non,?,small,?,cell,lung,carcinoma,.}","{interpretation,:,deletion,mutation,in,eXon,19,mostly,involve,the,lrea,motif,be,report,to,correlate,with,responsiveness,to,egfr,tyrosine,kinase,inhibitor,in,patient,with,non,?,small,?,cell,lung,carcinoma,.}","{NN,:,NN,NNS,IN,NNP,CD,RB,VBG,DT,NN,NN,VBP,VBN,TO,VB,IN,NN,TO,NN,NN,NN,NN,IN,NNS,IN,JJ,JJ,JJ,NN,NN,NN,NN,.}","{16,0,4,1,10,5,6,10,4,13,13,10,16,0,18,16,0,18,0,25,25,25,18,0,25,0,35,35,35,35,35,35,27,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_80,"COMMENT : Forty percent ( 40 % ) or more tumor cellularity is optimal for this mutation analysis .","{COMMENT,:,Forty,percent,(,40,%,),or,more,tumor,cellularity,is,optimal,for,this,mutation,analysis,.}","{COMMENT,:,forty,percent,(,40,%,),or,more,tumor,cellularity,be,optimal,for,this,mutation,analysis,.}","{NNP,:,CD,NN,CD,CD,NN,CD,CC,JJR,NN,NN,VBZ,JJ,IN,DT,NN,NN,.}","{0,0,4,14,7,7,4,4,0,4,12,8,14,1,0,18,18,14,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_81,"The sample submitted showed 80 % tumor cellularity upon pathologist review .","{The,sample,submitted,showed,80,%,tumor,cellularity,upon,pathologist,review,.}","{the,sample,submit,show,80,%,tumor,cellularity,upon,pathologist,review,.}","{DT,NN,VBN,VBD,CD,NN,NN,NN,IN,NN,NN,.}","{2,4,2,0,6,8,8,4,0,11,4,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_82,"E746_A750del5 corresponds to 2236_2250de115 .","{E746_A750del5,corresponds,to,2236_2250de115,.}","{e746_a750del5,correspond,to,2236_2250de115,.}","{NN,VBZ,TO,CD,.}","{2,0,0,2,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_83,"A frequently occurring sequence change 2361G > A ( Q787Q ) was identified .","{A,frequently,occurring,sequence,change,2361G,>,A,(,Q787Q,),was,identified,.}","{a,frequently,occur,sequence,change,2361g,>,a,(,q787q,),be,identify,.}","{DT,RB,VBG,NN,NN,NN,JJR,DT,CD,NN,NN,VBD,VBN,.}","{6,3,6,6,6,0,6,11,11,11,13,13,7,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_84,"This polymorphism is known not to have clinical significance .","{This,polymorphism,is,known,not,to,have,clinical,significance,.}","{this,polymorphism,be,know,not,to,have,clinical,significance,.}","{DT,NN,VBZ,VBN,RB,TO,VB,JJ,NN,.}","{2,4,4,0,7,7,4,9,7,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_85,"Mutations in the tyrosine domain of the epidennal growth factor receptor ( EGFR ) gene are reported to be associated with differential responsiveness or resistance to EGFR tyrosine kinase inhibitor ( TKI ) therapies .","{Mutations,in,the,tyrosine,domain,of,the,epidennal,growth,factor,receptor,(,EGFR,),gene,are,reported,to,be,associated,with,differential,responsiveness,or,resistance,to,EGFR,tyrosine,kinase,inhibitor,(,TKI,),therapies,.}","{mutation,in,the,tyrosine,domain,of,the,epidennal,growth,factor,receptor,(,egfr,),gene,be,report,to,be,associate,with,differential,responsiveness,or,resistance,to,egfr,tyrosine,kinase,inhibitor,(,tkus,),therapy,.}","{NNS,IN,DT,NN,NN,IN,DT,JJ,NN,NN,NN,CD,NN,NN,NN,VBP,VBN,TO,VB,VBN,IN,JJ,NN,CC,NN,TO,NN,NN,NN,NN,NN,NN,CD,NNS,.}","{17,0,5,5,1,0,11,11,11,11,5,15,15,15,11,17,0,20,20,17,0,23,20,0,23,0,32,32,32,32,32,20,34,32,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_86,"The objective response rate among patients with a sensitizing mutation ranges from 55 to 82 % .","{The,objective,response,rate,among,patients,with,a,sensitizing,mutation,ranges,from,55,to,82,%,.}","{the,objective,response,rate,among,patient,with,a,sensitize,mutation,range,from,55,to,82,%,.}","{DT,JJ,NN,NN,IN,NNS,IN,DT,VBG,NN,NNS,IN,CD,TO,CD,NN,.}","{4,4,4,0,0,4,0,11,11,11,6,0,15,15,16,11,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_87,"This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain ; based on the current literature most mutations in non ? small ? cell lung carcinoma ( NSCLC ) are expected to occur in these exons .","{This,assay,analyzes,exons,18-21,of,the,EGFR,tyrosine,kinase,domain,;,based,on,the,current,literature,most,mutations,in,non,?,small,?,cell,lung,carcinoma,(,NSCLC,),are,expected,to,occur,in,these,exons,.}","{this,assay,analyze,exon,18-21,of,the,egfr,tyrosine,kinase,domain,;,base,on,the,current,literature,most,mutation,in,non,?,small,?,cell,lung,carcinoma,(,nsclc,),be,expect,to,occur,in,these,exon,.}","{DT,NN,VBZ,NNS,CD,IN,DT,NN,NN,NN,NN,:,VBN,IN,DT,JJ,NN,JJS,NNS,IN,JJ,JJ,JJ,NN,NN,NN,NN,CD,NN,NN,VBP,VBN,TO,VB,IN,DT,NNS,.}","{2,3,0,3,4,0,11,11,11,11,4,0,0,33,17,17,33,20,17,0,28,28,28,28,28,28,20,31,31,33,33,3,35,33,0,38,35,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_88,"Mutations present in less than 10-20 % of extracted DNA may not be detected by this method .","{Mutations,present,in,less,than,10-20,%,of,extracted,DNA,may,not,be,detected,by,this,method,.}","{mutation,present,in,less,than,10-20,%,of,extract,dna,may,not,be,detect,by,this,method,.}","{NNS,JJ,IN,JJR,IN,CD,NN,IN,VBN,NN,MD,RB,VB,VBN,IN,DT,NN,.}","{14,1,0,5,6,7,2,0,10,7,14,14,14,0,0,17,14,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_89,"Mutation status in a sample may change during tumor progression or the course of therapy ; therefore this result can not be used to infer the presence or absence of a mutation in another sample or sub ? sample obtained from this tumor .","{Mutation,status,in,a,sample,may,change,during,tumor,progression,or,the,course,of,therapy,;,therefore,this,result,can,not,be,used,to,infer,the,presence,or,absence,of,a,mutation,in,another,sample,or,sub,?,sample,obtained,from,this,tumor,.}","{mutation,status,in,a,sample,may,change,during,tumor,progression,or,the,course,of,therapy,;,therefore,this,result,can,not,be,use,to,infer,the,presence,or,absence,of,a,mutation,in,another,sample,or,sub,?,sample,obtain,from,this,tumor,.}","{NN,NN,IN,DT,NN,MD,VB,IN,NN,NN,CC,DT,NN,IN,NN,:,RB,DT,NN,MD,RB,VB,VBN,TO,VB,DT,NN,CC,NN,IN,DT,NN,IN,DT,NN,CC,NN,CD,NN,VBN,IN,DT,NN,.}","{2,7,0,5,2,7,0,0,10,7,0,13,10,0,13,0,24,20,24,24,24,24,7,26,24,28,26,0,28,0,33,28,0,36,33,0,40,40,33,40,0,44,41,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_90,"This test is validated for non ? small cell lung carcinoma .","{This,test,is,validated,for,non,?,small,cell,lung,carcinoma,.}","{this,test,be,validate,for,non,?,small,cell,lung,carcinoma,.}","{DT,NN,VBZ,VBN,IN,JJ,JJ,JJ,NN,NN,NN,.}","{2,4,4,0,0,11,11,11,11,11,4,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_91,"The clinical significance and utility of this test in other tumor types is unknown .","{The,clinical,significance,and,utility,of,this,test,in,other,tumor,types,is,unknown,.}","{the,clinical,significance,and,utility,of,this,test,in,other,tumor,type,be,unknown,.}","{DT,JJ,NN,CC,NN,IN,DT,NN,IN,JJ,NN,NNS,VBZ,JJ,.}","{3,3,14,0,14,0,8,3,0,12,12,8,14,0,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_92,"METHOD/LIMITATION : Tissue sections are reviewed by a pathologist and relevant tumor is selected for analysis .","{METHOD/LIMITATION,:,Tissue,sections,are,reviewed,by,a,pathologist,and,relevant,tumor,is,selected,for,analysis,.}","{METHOD/LIMITATION,:,tissue,section,be,review,by,a,pathologist,and,relevant,tumor,be,select,for,analysis,.}","{NNP,:,NN,NNS,VBP,VBN,IN,DT,NN,CC,JJ,NN,VBZ,VBN,IN,NN,.}","{0,0,4,6,6,1,0,9,6,0,12,14,14,6,0,14,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_93,"DNA is isolated from the samples quantified and amplified by polymerase chain reaction ( PCR ) using primers to exons 18-21 of the EGFR gene .","{DNA,is,isolated,from,the,samples,quantified,and,amplified,by,polymerase,chain,reaction,(,PCR,),using,primers,to,exons,18-21,of,the,EGFR,gene,.}","{dna,be,isolate,from,the,sample,quantify,and,amplify,by,polymerase,chain,reaction,(,pcr,),use,primer,to,exon,18-21,of,the,egfr,gene,.}","{NN,VBZ,VBN,IN,DT,NNS,VBN,CC,VBN,IN,NN,NN,NN,CD,NN,NN,VBG,NNS,TO,NNS,CD,IN,DT,NN,NN,.}","{10,3,0,0,6,3,3,0,3,0,17,17,17,17,17,10,17,18,0,18,21,0,26,26,21,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_94,"PCR products are analyzed by bi ? directional direct DNA sequencing using capillary gel electrophoresis and ?uorescence detection .","{PCR,products,are,analyzed,by,bi,?,directional,direct,DNA,sequencing,using,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{pcr,product,be,analyze,by,bus,?,directional,direct,dna,sequencing,use,capillary,gel,electrophoresis,and,?uorescence,detection,.}","{NN,NNS,VBP,VBN,IN,NN,CD,JJ,JJ,NN,NN,VBG,JJ,NN,NN,CC,NN,NN,.}","{2,4,4,0,0,4,11,11,11,11,4,11,15,15,12,0,18,12,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_95,"False positive or negative results may occur for reasons that include genetic Variants or somatic heterogeneity of the tissue sample .","{False,positive,or,negative,results,may,occur,for,reasons,that,include,genetic,Variants,or,somatic,heterogeneity,of,the,tissue,sample,.}","{false,positive,or,negative,result,may,occur,for,reason,that,include,genetic,variant,or,somatic,heterogeneity,of,the,tissue,sample,.}","{JJ,JJ,CC,JJ,NNS,MD,VB,IN,NNS,WDT,VBP,JJ,NNS,CC,JJ,NN,IN,DT,NN,NN,.}","{5,5,0,2,7,7,0,0,7,11,9,13,11,0,16,13,0,20,20,16,0}","{}"
TCGA-97-8552, TCGA-97-8552SENT_96,"REFERENCES :","{REFERENCES,:}","{reference,:}","{NNS,:}","{0,0}","{}"
